ADMA Biologics Inc. (ADMA)
NASDAQ: ADMA
· Real-Time Price · USD
16.86
-0.11 (-0.65%)
At close: Aug 15, 2025, 1:05 PM
-0.65% (1D)
| Bid | 16.85 |
| Market Cap | 4.02B |
| Revenue (ttm) | 474.17M |
| Net Income (ttm) | 208.93M |
| EPS (ttm) | 0.85 |
| PE Ratio (ttm) | 19.84 |
| Forward PE | 18.36 |
| Analyst | Strong Buy |
| Ask | 16.87 |
| Volume | 735,644 |
| Avg. Volume (20D) | 3,042,288 |
| Open | 16.88 |
| Previous Close | 16.97 |
| Day's Range | 16.61 - 16.97 |
| 52-Week Range | 13.50 - 25.67 |
| Beta | 0.38 |
About ADMA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ADMA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ADMA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
ADMA Biologics Inc. is scheduled to release its earnings on
Nov 6, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-9.65%
ADMA Biologics shares are trading lower after the ...
Unlock content with
Pro Subscription
1 week ago
-2.22%
ADMA Biologics shares are trading lower after the company reported worse-than-expected Q2 revenue results and issued FY26 revenue guidance below estimates.
1 week ago · fool.com
Adma Biologics (ADMA) Q2 Revenue Up 14%Adma Biologics (ADMA) Q2 Revenue Up 14%
